Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01374841
Recruitment Status : Recruiting
First Posted : June 16, 2011
Last Update Posted : August 10, 2016
Information provided by (Responsible Party):
European Institute of Oncology